APG Asset Management
LEGN icon

APG Asset Management’s Legend Biotech LEGN Stock Holding History

APG Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,600
Closed -$233K – 829
2022
Q3 		$233K Sell
5,600
-400
-7% -$18.8K ﹤0.01% 806
2022
Q2 		$316K Sell
6,000
-4,800
-44% -$203K ﹤0.01% 806
2022
Q1 		$353K Buy
+10,800
New +$427K ﹤0.01% 858

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

APG Asset Management's LEGN Position: Q4 2022 in Review

APG Asset Management sold out of Legend Biotech (LEGN) in Q4 2022, closing a stake of 5,600 shares — an estimated $233K sold.

APG Asset Management first reported a position in LEGN in Q1 2022 and held it in 3 quarters. The position peaked at $353K in Q1 2022. 170 funds tracked by Wall St. Rank hold LEGN as of Q4 2022.

  • APG Asset Management reported no remaining Legend Biotech position as of Q4 2022 after selling out during the quarter.
  • APG Asset Management sold 5,600 Legend Biotech shares in Q4 2022, an estimated $233K.
  • APG Asset Management first reported a position in Legend Biotech in Q1 2022 and held it in 3 quarters.
  • APG Asset Management's Legend Biotech position peaked at $353K in Q1 2022.
  • 170 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2022.

Based on APG Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.